First Time Loading...
J

Jinneng Science & Technology Co Ltd
SSE:603113

Watchlist Manager
Jinneng Science & Technology Co Ltd
SSE:603113
Watchlist
Price: 7.05 CNY 0.57% Market Closed
Updated: May 18, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

18.3B
+6%
Assets
Growth Rates:
1 Year
+12%
3 Years
+52%
5 Years
+169%
7 Years
-
10 Years
-
9.5B
+11%
Liabilities
Growth Rates:
1 Year
+25%
3 Years
+138%
5 Years
+394%
7 Years
-
10 Years
-
8.8B
+2%
Equity
Growth Rates:
1 Year
+1%
3 Years
+9%
5 Years
+80%
7 Years
-
10 Years
-

Balance Sheet Decomposition
Jinneng Science & Technology Co Ltd

18.3B
Assets
9.5B
Liabilities
18.3B
Assets
9.5B
Liabilities
Current Assets 7B
Cash & Short-Term Investments 1.2B
Receivables 3.3B
Other Current Assets 2.5B
Non-Current Assets 11.3B
PP&E 9.9B
Intangibles 1.1B
Other Non-Current Assets 292.5m
Current Liabilities 7.1B
Accounts Payable 2.2B
Accrued Liabilities 132.3m
Short-Term Debt 4.4B
Other Current Liabilities 396.6m
Non-Current Liabilities 2.5B
Long-Term Debt 2.2B
Other Non-Current Liabilities 282.1m

Balance Sheet
Jinneng Science & Technology Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
61
41
28
431
933
314
319
924
939
1 216
Cash
0
0
0
0
0
0
0
924
939
1 216
Cash Equivalents
61
41
28
431
933
314
319
0
0
0
Short-Term Investments
0
0
0
0
0
1 058
1 576
1 634
1 418
13
Total Receivables
553
404
528
616
715
856
1 220
994
2 739
3 302
Accounts Receivables
401
293
298
428
537
397
405
678
1 051
1 361
Other Receivables
152
111
230
188
178
459
815
316
1 687
1 941
Inventory
364
296
484
523
552
568
546
1 151
1 002
1 119
Other Current Assets
78
48
156
1 084
1 276
1 086
898
358
1 055
1 375
Total Current Assets
1 055
789
1 196
2 654
3 477
3 883
4 559
5 060
7 154
7 024
PP&E Net
2 131
2 125
1 926
2 210
2 383
3 830
6 466
6 972
7 967
9 895
PP&E Gross
0
2 125
1 926
2 210
2 383
3 830
6 466
6 972
7 967
9 895
Accumulated Depreciation
0
1 377
1 537
1 931
2 246
2 532
3 029
3 553
3 593
4 279
Intangible Assets
293
287
280
317
809
820
926
976
1 002
1 072
Long-Term Investments
0
0
0
30
29
30
0
0
0
0
Other Long-Term Assets
46
49
53
91
97
101
114
105
203
292
Total Assets
3 526
N/A
3 250
-8%
3 456
+6%
5 302
+53%
6 795
+28%
8 663
+27%
12 065
+39%
13 114
+9%
16 326
+24%
18 284
+12%
Liabilities
Accounts Payable
375
311
335
433
478
594
1 357
1 420
1 195
2 177
Accrued Liabilities
32
33
63
47
169
71
178
114
123
132
Short-Term Debt
479
235
161
286
404
400
924
1 361
4 630
4 357
Current Portion of Long-Term Debt
136
204
161
88
40
10
0
0
3
6
Other Current Liabilities
72
49
141
157
456
230
420
397
396
391
Total Current Liabilities
1 094
832
862
1 012
1 546
1 305
2 879
3 292
6 347
7 063
Long-Term Debt
378
299
138
50
10
1 139
859
858
1 023
2 184
Deferred Income Tax
0
0
0
0
0
16
20
26
59
73
Other Liabilities
235
228
259
386
373
310
249
194
189
209
Total Liabilities
1 707
N/A
1 359
-20%
1 259
-7%
1 447
+15%
1 929
+33%
2 769
+44%
4 007
+45%
4 370
+9%
7 618
+74%
9 529
+25%
Equity
Common Stock
599
599
599
676
676
676
849
855
855
848
Retained Earnings
338
410
715
1 394
2 406
3 067
3 960
4 590
4 541
4 597
Additional Paid In Capital
882
882
882
1 784
1 784
1 784
3 068
3 133
3 133
3 065
Treasury Stock
0
0
0
0
0
0
75
75
75
0
Other Equity
0
0
1
0
0
366
258
241
253
246
Total Equity
1 819
N/A
1 891
+4%
2 196
+16%
3 854
+76%
4 866
+26%
5 894
+21%
8 059
+37%
8 744
+9%
8 707
0%
8 756
+1%
Total Liabilities & Equity
3 526
N/A
3 250
-8%
3 456
+6%
5 302
+53%
6 795
+28%
8 663
+27%
12 065
+39%
13 114
+9%
16 326
+24%
18 284
+12%
Shares Outstanding
Common Shares Outstanding
599
599
599
676
676
676
841
848
848
848

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.